SANTA CLARA, Calif., Jan 29, 2008 (BUSINESS WIRE) -- XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide
access via the World Wide Web to its presentation at the Merrill Lynch
Global Pharmaceutical, Biotechnology and Medical Device Conference.
The live presentation will occur at 5:00 a.m. Pacific Time (8:00 a.m.
Eastern Time) on Wednesday, February 6, 2008. A replay of the
presentation will also be available.
To access the live presentation via the Web, please go to
www.XenoPort.com. Please connect to the Web site at least 15 minutes
prior to the live presentation to ensure adequate time for any
software downloads that may be necessary to listen to the Webcast.
A replay of the Webcast can be accessed for a minimum of one week
and will be available approximately 24 hours after the live
XenoPort, Inc. is a biopharmaceutical company focused on
developing a portfolio of internally discovered product candidates
that utilize the body's natural nutrient transport mechanisms to
improve the therapeutic benefits of existing drugs. XenoPort's most
advanced product candidate, XP13512, has successfully completed two
pivotal trials in its Phase 3 clinical program for the treatment of
restless legs syndrome and has successfully completed a Phase 2a
clinical trial for the management of post-herpetic neuralgia. XenoPort
has also reported positive results from a Phase 2a clinical trial of
its second product candidate, XP19986, in patients with
gastroesophageal reflux disease.
To learn more about XenoPort, please visit the Web site at
XenoPort is a registered U.S. trademark.
SOURCE: XenoPort, Inc.
Jackie Cossmon, 408-616-7220